Cardiac Science Inc. DFIB (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiac Science Inc. DFIB (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ken W who wrote (117)	11/30/2002 5:58:13 PM
From: Harry J.	Read Replies (1) of 174

Excited? I guess the cross-marketing agreement is preferable to (a) three years of lawyers' fees [patent lawyers' fees at that!!] or (b) another dilution of "my" share of the company upon the issuance of manymany shares to acquire Zoll. Then again, I went to www.zoll.com to read about it. It does around $115 million in sales. Cross-marketing may result in some economies of scale for both companies. Oh, yeah, I was going to post a story that appeared in 'The Washington Post' a couple weeks ago about the home use of defib'rs. It was a bit more positive than the one posted on thishere discussion list a couple posts ago. Still in for the long term - Harry J. PS - disclaimer: yeah, I'm a lawyer; but I'm retired so it's OK for me to pick on them. Also, my capital, as represented by my puny pile of shares, is hardly diluted significantly by these periodic acquisitions; I just like to whine. 8-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next